To our knowledge, this is the first epidemiological study to focus on the DSB signalling pathway in bladder cancer, evaluating the effect of potentially functional variants in ATM, MRE11, NBS1, RAD50 and H2AX on bladder cancer risk. The gene discussed is H2AX; the disease is urinary bladder carcinoma.